- Report
- October 2024
- 93 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2024
- 130 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- December 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- December 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- October 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- August 2024
- 200 Pages
Global
From €3692EUR$3,869USD£3,094GBP
- Report
- September 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- July 2024
- 153 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- July 2024
- 158 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- November 2024
- 53 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- January 2025
- 150 Pages
United States
From €5679EUR$5,950USD£4,758GBP
- Report
- April 2024
- 86 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2024
- 85 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2024
- 70 Pages
Africa, Middle East
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2024
- 91 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- June 2024
- 90 Pages
United States
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2018
- 514 Pages
Global
From €3339EUR$3,499USD£2,798GBP
- Report
- January 2024
- 251 Pages
Global
From €5374EUR$5,827USD£4,350GBP
- Report
- January 2023
- 330 Pages
Global
From €4879EUR$5,292USD£3,950GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more